Roche Holding AG (DE:RHOA)

FRANKFURT:RHOA

RHOA

Roche Holding AG

RESEARCH TOOLSreports

Want to see DE:RHOA full AI Analyst Report?

Roche Holding AG (RHOA) Stock Forecast & Price Target

72 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

RHOA Analyst Ratings

Moderate Buy

7 Buy

4 Hold

2 Sell

Based on 13 analysts giving stock ratings to

Roche

Holding AG

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

RHOA Stock 12 Month Forecast

Average Price Target

€380.39

▲(11.11% Upside)

Based on 13 Wall Street analysts offering 12 month price targets for Roche Holding AG in the last 3 months. The average price target is €380.39 with a high forecast of €451.63 and a low forecast of €250.30. The average price target represents a 11.11% change from the last price of €342.35.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"236":"€236","290":"€290","344":"€344","398":"€398","452":"€452"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":451.62582499999996,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€451.63</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":380.39458863636366,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€380.39</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":250.29864999999998,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€250.30</span>\n  </div></div>","useHTML":true}}],"tickPositions":[236,290,344,398,452],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jul<br/>2025","6":"Oct<br/>2025","9":"Jan<br/>2026","12":"Apr<br/>2026","25":"Apr<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,348.25,356.20198653846154,364.1539730769231,372.1059596153846,380.05794615384616,388.0099326923077,395.96191923076924,403.9139057692307,411.86589230769226,419.8178788461538,427.76986538461534,435.7218519230769,443.6738384615384,{"y":451.62582499999996,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,348.25,350.72266066433565,353.19532132867135,355.667981993007,358.14064265734265,360.61330332167836,363.085963986014,365.55862465034966,368.0312853146853,370.503945979021,372.97660664335666,375.4492673076923,377.921927972028,{"y":380.39458863636366,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,348.25,340.7152807692308,333.1805615384615,325.6458423076923,318.1111230769231,310.5764038461538,303.0416846153846,295.5069653846154,287.97224615384613,280.4375269230769,272.90280769230765,265.36808846153843,257.8333692307692,{"y":250.29864999999998,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":237.918,"date":1743465600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 18</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":237.918,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 14</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":275.178,"date":1748736000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 15</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":269.792,"date":1751328000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 16</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":261.982,"date":1754006400000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 14</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":268.24,"date":1756684800000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 16</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":291.091,"date":1759276800000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 16</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":271.199,"date":1761955200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 20</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":323.547,"date":1764547200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 17</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":342.856,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 9</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":373.809,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 21, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 7</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":391.274,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 22, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 6</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":348.25,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 6</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target€451.63

Average Price Target€380.39

Lowest Price Target€250.30

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Matthew Weston

UBS

€417.89

Buy

22.07%

Upside

Reiterated

04/24/26

Wall Street Analysts Are Bullish on Top Healthcare Picks

James Quigley

Goldman Sachs

€379.8→€376.54

Hold

9.99%

Upside

Reiterated

04/24/26

Analysts Offer Insights on Healthcare Companies: Roche Holding AG (Other OTC: RHHVF) and Sutro Biopharma (NASDAQ: STRO)

David Evans

Kepler Capital

€451.63

Buy

31.92%

Upside

Reiterated

04/23/26

Analysts Offer Insights on Healthcare Companies: Roche Holding AG (Other OTC: RHHVF) and Sanofi (Other OTC: SNYNF)

Michael Leuchten

Jefferies

€250.3

Sell

-26.89%

Downside

Reiterated

04/23/26

Jefferies Reaffirms Their Sell Rating on Roche Holding AG (RHHVF)

James Gordon CFA

Barclays

€446.18

Buy

30.33%

Upside

Reiterated

04/22/26

Analysts Conflicted on These Healthcare Names: InnovAge Holding (NASDAQ: INNV) and Roche Holding AG (Other OTC: RHHVF)

Justin Smith

Bernstein

€359.12→€429.86

Buy

25.56%

Upside

Reiterated

03/12/26

Wall Street Analysts Are Bullish on Top Healthcare Picks

Emmanuel Papadakis

Deutsche Bank

€370.01

Hold

8.08%

Upside

Reiterated

03/12/26

Analysts Are Neutral on These Healthcare Stocks: RegenXBio (RGNX), Roche Holding AG (RHHVF)

Richard Vosser

J.P. Morgan

€380.89→€353.68

Hold

3.31%

Upside

Reiterated

03/12/26

J.P. Morgan Reaffirms Their Hold Rating on Roche Holding AG (RHHVF)

Luisa Hector

Berenberg Bank

€370.01

Hold

8.08%

Upside

Reiterated

03/11/26

Analysts Offer Insights on Healthcare Companies: Roche Holding AG (Other OTC: RHHVF), Centene (NYSE: CNC) and LifeMD (NASDAQ: LFMD)

Unknown Analyst

HSBC

Not Ranked

HSBC

€418.98→€397.21

Buy

16.03%

Upside

Reiterated

03/10/26

Roche Holding AG target price reduced from CHF385 to CHF365, but we maintain our Buy rating due to pipeline catalysts.

Graham Parry

Citi

―

Buy

―

Reiterated

03/10/26

Analysts Offer Insights on Healthcare Companies: Roche Holding AG (Other OTC: RHHVF), BioNTech SE (NASDAQ: BNTX) and Skye Bioscience (NASDAQ: SKYE)

Sarita Kapila

Morgan Stanley

€321.04

Sell

-6.23%

Downside

Reiterated

03/02/26

Roche: Fenebrutinib Safety Concerns Skew Risk‑Reward, Driving Sell Rating

Elmar Kraus

DZ BANK AG

―

Buy

―

Reiterated

02/02/26

Analysts' Top Healthcare Picks: Nektar Therapeutics (NKTR), Roche Holding AG (RHHVF)

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Matthew Weston

UBS

€417.89

Buy

22.07%

Upside

Reiterated

04/24/26

Wall Street Analysts Are Bullish on Top Healthcare Picks

James Quigley

Goldman Sachs

€379.8→€376.54

Hold

9.99%

Upside

Reiterated

04/24/26

Analysts Offer Insights on Healthcare Companies: Roche Holding AG (Other OTC: RHHVF) and Sutro Biopharma (NASDAQ: STRO)

David Evans

Kepler Capital

€451.63

Buy

31.92%

Upside

Reiterated

04/23/26

Analysts Offer Insights on Healthcare Companies: Roche Holding AG (Other OTC: RHHVF) and Sanofi (Other OTC: SNYNF)

Michael Leuchten

Jefferies

€250.3

Sell

-26.89%

Downside

Reiterated

04/23/26

Jefferies Reaffirms Their Sell Rating on Roche Holding AG (RHHVF)

James Gordon CFA

Barclays

€446.18

Buy

30.33%

Upside

Reiterated

04/22/26

Analysts Conflicted on These Healthcare Names: InnovAge Holding (NASDAQ: INNV) and Roche Holding AG (Other OTC: RHHVF)

Justin Smith

Bernstein

€359.12→€429.86

Buy

25.56%

Upside

Reiterated

03/12/26

Wall Street Analysts Are Bullish on Top Healthcare Picks

Emmanuel Papadakis

Deutsche Bank

€370.01

Hold

8.08%

Upside

Reiterated

03/12/26

Analysts Are Neutral on These Healthcare Stocks: RegenXBio (RGNX), Roche Holding AG (RHHVF)

Richard Vosser

J.P. Morgan

€380.89→€353.68

Hold

3.31%

Upside

Reiterated

03/12/26

J.P. Morgan Reaffirms Their Hold Rating on Roche Holding AG (RHHVF)

Luisa Hector

Berenberg Bank

€370.01

Hold

8.08%

Upside

Reiterated

03/11/26

Analysts Offer Insights on Healthcare Companies: Roche Holding AG (Other OTC: RHHVF), Centene (NYSE: CNC) and LifeMD (NASDAQ: LFMD)

Unknown Analyst

HSBC

Not Ranked

HSBC

€418.98→€397.21

Buy

16.03%

Upside

Reiterated

03/10/26

Roche Holding AG target price reduced from CHF385 to CHF365, but we maintain our Buy rating due to pipeline catalysts.

Graham Parry

Citi

―

Buy

―

Reiterated

03/10/26

Analysts Offer Insights on Healthcare Companies: Roche Holding AG (Other OTC: RHHVF), BioNTech SE (NASDAQ: BNTX) and Skye Bioscience (NASDAQ: SKYE)

Sarita Kapila

Morgan Stanley

€321.04

Sell

-6.23%

Downside

Reiterated

03/02/26

Roche: Fenebrutinib Safety Concerns Skew Risk‑Reward, Driving Sell Rating

Elmar Kraus

DZ BANK AG

―

Buy

―

Reiterated

02/02/26

Analysts' Top Healthcare Picks: Nektar Therapeutics (NKTR), Roche Holding AG (RHHVF)

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Roche Holding AG

3 Months

xxx

Success Rate

14/18 ratings generated profit

Average Return

+8.55%

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 77.78% of your transactions generating a profit, with an average return of +8.55% per trade.

1 Year

Matthew WestonUBS

Success Rate

13/13 ratings generated profit

Average Return

+25.98%

Copying Matthew Weston's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +25.98% per trade.

2 Years

xxx

Success Rate

15/15 ratings generated profit

Average Return

+33.91%

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +33.91% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

RHOA Analyst Recommendation Trends

Rating

Dec 25

Jan 26

Feb 26

Mar 26

Apr 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, RHOA has received 19 Buy Ratings, 12 Hold Ratings, and 6 Sell Ratings. RHOA average Analyst price target in the past 3 months is 380.39.

Each month's total comprises the sum of three months' worth of ratings.

RHOA Financial Forecast

RHOA Earnings Forecast

Next quarter’s earnings estimate for RHOA is €11.60 with a range of €11.55 to €11.66. The previous quarter’s EPS was €9.12. RHOA beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year RHOA has Performed in-line its overall industry.

RHOA Sales Forecast

Next quarter’s sales forecast for RHOA is €17.17B with a range of €17.13B to €17.22B. The previous quarter’s sales results were €33.27B. RHOA beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year RHOA has Performed in-line its overall industry.

RHOA Stock Forecast FAQ

What is DE:RHOA’s average 12-month price target, according to analysts?

Based on analyst ratings, Roche Holding AG’s 12-month average price target is 380.39.

What is DE:RHOA’s upside potential, based on the analysts’ average price target?

Roche Holding AG has 11.11% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Roche Holding AG a Buy, Sell or Hold?

Roche Holding AG has a consensus rating of Moderate Buy, which is based on 7 buy ratings, 4 hold ratings and 2 sell ratings.

What is Roche Holding AG’s share price target?

The average share price target for Roche Holding AG is 380.39. This is based on 13 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €451.63 ,and the lowest forecast is €250.30. The average share price target represents 11.11% Increase from the current price of €342.35.

What do analysts say about Roche Holding AG?

Roche Holding AG’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 13 Wall Streets Analysts.

How can I buy shares of Roche Holding AG?

To buy shares of DE:RHOA, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Roche Holding AG (RHOA) Stock Forecast & Price Target

RHOA Analyst Ratings

RHOA Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Roche Holding AG

RHOA Analyst Recommendation Trends

RHOA Financial Forecast

RHOA Earnings Forecast

RHOA Sales Forecast

RHOA Stock Forecast FAQ

Detailed List of Analyst Forecasts